Cardiac arrhythmias frequently complicate the clinical management of patients with acute myocardial infarction (AMI). Multiple studies have established a significant association between diverse arrhythmias with a higher morbidity and mortality in …

Acute myocardial infarction is still a leading cause of death worldwide, accounting for roughly three million deaths yearly [ 1 ]. It is estimated that 23.6 million people will die from cardiovascular diseases (CVDs) by 2030 [ 2 ]. Acute coronary …

Acute myocardial infarction (AMI) is a severe type of ischemic heart disease. Globally, approximately 9 and 182 million deaths and disabilities, respectively, were caused by AMI in 2019 [ 1 – 3 ]. Creatine kinase-MB (CK-MB) is a clinically …

Myocardial infarctions (MIs) that are asymptomatic or with minor and atypical symptoms are often diagnosed through routine electrocardiographic (ECG) examination. Silent myocardial infarction (SMI) is characterized by ECG evidence of MI without a …

As the most serious ischaemic heart disease, acute myocardial infarction (AMI) is recognized as a leading cause of cardiovascular disease (CVD) morbidity and mortality worldwide [ 1 , 2 ]. AMI causes more than 24 million deaths in the United States …

The occurrence of a post-myocardial infarction ventricular septal perforation (VSP) is an infrequent but often fatal complication, affecting less than 1% of patients who have experienced myocardial infarction (MI) in the modern era of early …

The chronic inflammation in cancer predisposes patients to arterial and venous thromboembolism, including myocardial infarction [ 1 ]. Not only that, but chemotherapy itself is increasingly associated with cardiotoxicity with reported cases of …

Acute myocardial infarction (AMI) is a life-threatening emergency associated with high morbidity and mortality [ 1 , 2 ]. Over the past several decades, advances in evidence-based AMI care, including early diagnosis, rapid reperfusion strategies …

The management of patients with acute myocardial infarction (AMI) and large thrombus burden (LTB) remains challenging. Despite the advent of potent antithrombotic regimens, percutaneous coronary intervention (PCI) in AMI cases with LTB often …

Paradoxical embolism (PDE) occurring via a patent foramen ovale (PFO) represents one of the most significant risk factors for systemic embolic occurrences, such as cryptogenic stroke. This phenomenon is rare accounting for less than 2% of all …

The management of perioperative acute myocardial infarction (AMI) following oncologic neurosurgery requires balancing competing risks of myocardial ischemia and postoperative bleeding. There are limited human data to establish the safest timing of …

Though myocardial infarction (MI) in pigs is a well-established translational large animal model, it has not yet been widely used for immunotherapy studies, and a comprehensive description of the immune response to MI in this species is lacking.

Over two decades ago cold-induced RNA-binding protein (CIRP) was discovered during the investigation of the mechanisms by which mammals adapt to cold stress. Previous studies have demonstrated that as a general stress-responsive protein, the …